纳米材料辅助的胰腺癌治疗药物
Yaqi Liu1,2, Huachun Xu3, Shihao Bai2
1College of Chemical Engineering, Zhejiang University of Technology, Hangzhou 310014, China.
Regenerative biomaterials
|June 30, 2025
概括
新型纳米材料为胰腺癌提供了增强的成像和治疗,改善了早期检测和治疗. 需要进一步的研究来克服临床应用的挑战.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 胰腺癌是一种高度致命的恶性瘤,诊断和治疗选择有限.
- 目前在成像和治疗方面的局限性阻碍了早期检测和有效管理.
- 精确的治疗术对于改善胰腺癌的结果至关重要.
研究的目的:
- 审查用于胰腺癌治疗的纳米材料应用的最新进展.
- 突出纳米材料在增强诊断成像和精密治疗方面的潜力.
- 讨论当前的挑战和该领域的未来方向.
主要方法:
- 关于用于胰腺癌的纳米材料的最新文献的审查.
- 讨论使用纳米材料的各种成像方式 (磁性,光学,声学,放射性).
- 通过纳米材料增强的治疗策略 (化学动力学,基于光的,声动力学,基因疗法) 的探索.
主要成果:
- 纳米材料显示了在胰腺癌诊断和治疗中提高准和精度的潜力.
- 多功能纳米材料提高了成像能力和治疗效率.
- 不同的应用涵盖了先进的成像技术和新的治疗方式.
结论:
- 纳米材料显示显著的希望通过改进的theranostics彻底改变胰腺癌的管理.
- 克服针对性,稳定性,生物障碍和临床翻译方面的挑战至关重要.
- 在纳米材料辅助诊断和治疗领域的持续创新可以改善患者的预后.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...